Pages that link to "Q43822630"

The following pages link to Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine (Q43822630):

Displaying 38 items.

• Future Vaccination Strategies against Tuberculosis: Thinking outside the Box (Q22252427) (← links)
• Vaccines against tuberculosis: where are we and where do we need to go? (Q26992233) (← links)
• (Q28376762) (← links)
• Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses (Q30408875) (← links)
• Promises and pitfalls of meta-analysis in vaccine research. (Q33589142) (← links)
• Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation (Q33766076) (← links)
• Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK. (Q33914166) (← links)
• Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination (Q34127432) (← links)
• Variation in protection by BCG: implications of and for heterologous immunity (Q34288541) (← links)
• Cofactors that may influence vaccine responses (Q34297930) (← links)
• Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes (Q34985591) (← links)
• Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda (Q35049474) (← links)
• Performance of Tuberculin Skin Test Measured against Interferon Gamma Release Assay as Reference Standard in Children (Q35128566) (← links)
• A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements (Q35535389) (← links)
• Interplay between innate and adaptive immunity in the development of non-infectious uveitis (Q35784059) (← links)
• Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study (Q35798137) (← links)
• The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda (Q35859543) (← links)
• The success and failure of BCG - implications for a novel tuberculosis vaccine (Q36191944) (← links)
• Immune responses to tuberculosis in developing countries: implications for new vaccines (Q36213975) (← links)
• Vaccines for tuberculosis: novel concepts and recent progress (Q36285657) (← links)
• Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. (Q36410721) (← links)
• Tuberculosis vaccines: current status and future prospects (Q36458393) (← links)
• The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link? (Q36565187) (← links)
• New vaccines for tuberculosis (Q37757648) (← links)
• Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants (Q39397075) (← links)
• Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination (Q39473407) (← links)
• Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children (Q39552628) (← links)
• Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis (Q40006239) (← links)
• Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns (Q40346950) (← links)
• The effect of bacille Calmette-Guérin vaccination at birth on immune response in China (Q41749256) (← links)
• The use of Bacille Calmette-Guérin vaccination in children (Q41870078) (← links)
• Guinea pig skin, a model for epidermal cellular and molecular changes induced by UVR in vivo and in vitro: effects on Mycobacterium bovis Bacillus Calmette-Guérin vaccination (Q45766962) (← links)
• Prospects for the use of new vaccines in developing countries: cost is not the only impediment. (Q53365722) (← links)
• Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential (Q57038792) (← links)
• ‘Proteomic contigs’ of Mycobacterium tuberculosis and Mycobacterium bovis (BCG) using novel immobilised pH gradients (Q73701359) (← links)
• BCG vaccination gets a boost (Q83158039) (← links)
• A systematic review of the impact of psychosocial factors on immunity: Implications for enhancing BCG response against tuberculosis (Q92465075) (← links)
• Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021 (Q111441919) (← links)